[Effect of beta-blocking agents talinolol and metipranolol in patients with thyrotoxicosis (author's transl)].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000328:Adult; D005260:Female; D006801:Humans; D006980:Hyperthyroidism / Q000188:drug therapy* / Q000503:physiopathology; D008297:Male; D014290:Metipranolol / Q000627:therapeutic use*; D008875:Middle Aged; D011412:Propanolamines / Q000627:therapeutic use*; D013599:Systole
D000319:Adrenergic beta-Antagonists; D011412:Propanolamines; C011550:talinolol; D014290:Metipranolol
Ucinek betablokátorů talinololu a metipranololu u nemocných s tyreotoxikózou.